Pharmaceutical Technology Europe-11-01-2010

There has been increasing cooperation between the EMA and the FDA in recent years, and this looks set to continue in the future.

Leading European experts from the pharmaceutical packaging industry explain how they are coping with industry trends.

Joint regulatory API inspections on the rise.

Discussing the key challenges that face cell-based bioprocess manufacturers today, how these challenges might be addressed and the innovations that could facilitate the process in the future.

Although there are no regulatory requirements or established pharmacopoeial techniques for the dissolution testing of inhaled drugs, such testing can potentially open up the opportunity to tailor formulation properties.

I recently attended the annual CPhI exhibition in Paris, which turned out to be a great event for the PTE team and I.

This article examines the difficulties in designing lyophilisation processes that can be faithfully scaled up to production volumes and suggests the most effective ways in which this can be achieved.

Generally, the pharma industry isn't doing enough to reduce the environmental impact of its packaging materials, but there are various historic reasons for this.